Non sequitur. I said "putting out data in a timely fashion" but yes its hard to compare when you won't announce the data of a placebo controlled trial. Mid year had come and gone. Will mid October? 125 days overdue and counting. Here's to hoping for positive results tomorrow.
It is interesting in comparison with Neurotrope's trials. I suppose we could have sat on and data mined before any release of top line data but IMO that isn't very fair to shareholders when top line isn't met. I would have become concerned when anavex "added" an additional 30 patients but the "n" never changed. My guess is something went wrong for them to have to do it but hopefully they were able to correct mid stream. Something very bizarre however when CEO goes to an investment conference 2 weeks before the end of september and says results will DEFINITELY be by the end of the month and yet here we are. Hopefully any day now will be this month. JMHO
News 
Market Data 
Discover 
